Microorganisms: Infectious Disease and Ecology

Blog entries about bacteria, viruses, fungi and other microorganisms.

What Happens When You Delay an Ebola Vaccine Booster by 18 Months?

Posted on by Shannon Sindermann

Ebola Virus Disease (EBOD) remains one of the most severe viral infections, with case fatality rates reaching 40% during the 2013-2016 West African outbreak that claimed over 11,000 lives (1). At this scale, durable protection isn’t optional.

Ebola Virus under the microscope

If you’ve followed vaccine development, you’ve probably noticed something counterintuitive. Shorter intervals between doses are not always better. SARS-CoV-2 mRNA vaccine studies have shown that extended intervals between doses enhance neutralizing antibody responses against multiple variants (5). Now, new research published in Nature Immunology suggests the same may be true for Ebola (1).

The findings challenge assumptions about how vaccine boosters should be timed and reveal something important about how our immune systems respond when given the space to do what they do best.

Continue reading “What Happens When You Delay an Ebola Vaccine Booster by 18 Months?”

The Molecular Blueprint for Virus-Resistant Cowpea

Posted on by Anna Bennett

Cowpea (Vigna unguiculata), a humble tan and black legume, is one of the most important food crops in the world. Grown across sub-Saharan Africa, Asia, and parts of the Americas, Cowpea provides protein-rich nutrition for hundreds of millions of people, making it a cornerstone of smallholder agriculture. But cowpea production faces a persistent threat: the cowpea aphid-borne mosaic virus (CABMV), a common virus that can devastate yields across entire growing regions.

A dark background with a wooden spoon holding tan and black beans scattered on the spoon and on the background.

What makes CABMV particularly difficult to combat is how the virus infects its host. Instead of relying on viral translational machinery, the virus hijacks the plant’s systems to replicate. CABMV targets a protein called eIF4E, a translation initiation factor that the plant needs to read its own genetic instructions and produce proteins. The virus produces a protein, VPg, that binds directly to eIF4E and redirects the plant’s translational machinery to produce viral proteins instead. The plant can’t simply get rid of eIF4E. Without it, protein synthesis stalls. So how can cowpea defend itself against a virus that exploits one of its most essential proteins?

A new study published in Agronomy by researchers at the Federal University of Pernambuco, the Federal University of Minas Gerais, and Embrapa Recursos Genéticos e Biotecnologia takes a comprehensive look at this problem from the inside out1. The team characterized all three members of the eIF4E gene family in cowpea  (eIF4E, eIF(iso)4E, and nCBP) across six cultivated varieties (cultivars) with known contrasting responses to CABMV infection. Two of those cultivars (Bajão and IT85F-2687) are resistant to the virus; the other four (Boca Negra, BR14 Mulato, Pingo de Ouro, and Santo Inácio) are susceptible to the virus.

Using a multi-omics approach that combined genomic, evolutionary and structural analyses, the researchers set out to answer a fundamental question: what makes some versions of eIF4E exploitable by the virus, and others not?

Continue reading “The Molecular Blueprint for Virus-Resistant Cowpea”

World Wildlife Conservation Day: Reflecting on the Role of Science in Protecting Threatened or Endangered Species and Ecosystems  

Posted on by Kelly Grooms
A sign reading “Wildlife Conservation Area — Please keep to marked footpaths” stands in the foreground of a grassy field, with rows of young crops and a line of trees under a partly cloudy sky.

December 4 marks World Wildlife Conservation Day, a day set aside to highlight global efforts to protect endangered species and preserve the biodiversity and ecosystems that sustain our planet. It is an opportunity to call attention to the serious threats posed by wildlife crimes, such as poaching and illegal trafficking, and a time to stand together against ongoing dangers to wildlife and their habitat.  

Every organism, from myxozoans to blue whales, has a place in the delicate balance of ecosystems. When these systems become unstable, the impact can be far reaching—affecting anything from crop loss and soil fertility to water and air quality. This World Wildlife Conservation Day we want to reflect on the role science can play in understanding and protecting the wildlife and ecosystems that support us all.  

Continue reading “World Wildlife Conservation Day: Reflecting on the Role of Science in Protecting Threatened or Endangered Species and Ecosystems  “

Therapeutics Come Alive: An Interview with PharmaBiome

Posted on by Nour Mozaffari

The next generation of medicine may not come in a pill or vial — but in a living community of microbes. Scientists at Pharmabiome, a Zurich-based biotechnology company, are leveraging their expertise in microbiome research to create truly “living” therapies.

More Than a Gut Feeling

All around us – and inside –exists an entire universe of microscopic organisms commonly referred to as the microbiome. In fact, our body contains more microbes than human cells, working hand in hand to maintain normal physiology. The most heavily colonized part of our body is our gastrointestinal (GI) tract – our gut – housing thousands of different bacteria, viruses and fungi. Collectively termed ‘gut microbiota’, this complex network of microorganisms helps us digest nutrients, produces essential metabolites, protects us against pathogens, and more.

The diverse species in our GI tract co-exist in a dynamic equilibrium, each fulfilling a defined set of functions and interacting with other species through cross-feeding mechanisms that, together, promote gut health. When this delicate balance is perturbed, be it through dietary changes, antibiotic treatments, or other factors, the effect ripples across the body. Increasing evidence suggests that gut dysbiosis actively contributes to pathological conditions ranging from inflammatory bowel disease (IBD) and obesity to neurological and autoimmune disorders. The good news is, as our understanding of gut ecology evolves, so does the potential to harness and reshape the microbiome to improve health.

Continue reading “Therapeutics Come Alive: An Interview with PharmaBiome”

Avoid the Summertime Blue-Greens— Know about Cyanobacteria Before You Hit the Water

Posted on by Kelly Grooms
Warning sign reading "ALGAE BLOOM – NO SWIMMING" posted in a lake with visible green algae floating on the water's surface, surrounded by lily pads and aquatic plants under a clear blue sky.

The weather is warming up (at least in the Northern Hemisphere). There is nothing more refreshing on a hot summer day than a dip in cool lake waters, so people everywhere are digging out their swimsuits and hitting the beach. Unfortunately, the same warm temperatures that drive us to the beach can also cause a potentially deadly overgrowth of blue-green algae —also called harmful algal blooms (HABs)—in the water of our favorite pond or lake.

Continue reading “Avoid the Summertime Blue-Greens— Know about Cyanobacteria Before You Hit the Water”

What’s Hiding in Your Mussels? 

Posted on by Shannon Sindermann
mussels

Fresh mussels might be a delicacy in many parts of the world, but a new study from Italy suggests they could also be carriers of something much less appetizing: infectious viruses and antibiotic resistance genes (ARGs). Published in Food and Environmental Virology, Venuti et al. (2025) investigated 60 mussel batches originating from the Campania (Southern Italy), Lazio and Puglia regions—and what they found raises important questions about food safety and environmental monitoring. 

Continue reading “What’s Hiding in Your Mussels? “

Measles and Immunosuppression—When Getting Well Means You Can Still Get Sick

Posted on by Kelly Grooms
26062330-March-7-Kelly-600x900-WEB

In 2000 measles was officially declared eliminated in the United States (1), meaning there had been no disease transmission for over 12 months. Unfortunately, recent years have shown us it was not gone for good. So far in 2025 there have been 6 outbreaks and 607 cases. Five hundred and sixty-seven of these cases (93%) are associated with an outbreak; seventy-four (12%) cases have resulted in hospitalization, and there has been one confirmed death, with another death under investigation (as of April 3, 2025; 2).  For comparison, there were two hundred and eighty-five total cases in 2024; one hundred and ninety-eight (69%) were associated with outbreaks; one hundred and fourteen (40%) cases resulted in hospitalization. There were no deaths (2).  

Help in Limiting a Dangerous Childhood Disease

Before the development of a vaccine in the 1960s, measles was practically a childhood rite of passage. This common childhood disease is not without teeth however. One out of every 20 children with measles develops pneumonia, 1 out of every 1,000 develops encephalitis (swelling of the brain), and 1 to 3 of every 1,000 dies from respiratory and neurological complications (3). In the years before a vaccine was available, it is estimated that there were between 3.5 and 5 million measles cases per year. (4). The first measles vaccine was licensed in the U.S. by John Enders in 1963, and not surprisingly, after the measles vaccine became widely used, the number of cases of measles plummeted. By 1970, there were under 1,000 cases (2).

Decreased Childhood Mortality from Other Infectious Diseases—An Unexpected Benefit

Surprisingly, with the disappearance of this childhood disease the number of childhood deaths from all infectious diseases dropped dramatically. As vaccination programs were instituted in England and parts of Europe, the same phenomenon was observed. Reduction or elimination of measles-related illness and death alone can’t explain the size of the decrease in childhood mortality. Although measles infection is associated with suppression of the immune system that will make the host vulnerable to other infections, these side effects were assumed to be short lived. In reality, the drop in mortality from infectious diseases following vaccination for measles lasted for years, not months (5).

Continue reading “Measles and Immunosuppression—When Getting Well Means You Can Still Get Sick”

One Health and H5N1: Promega’s Commitment to Holistic Solutions

Posted on by Promega

The global outbreak of highly pathogenic avian influenza A (H5N1) underscores the critical importance of proactive and integrated health strategies. With its zoonotic potential, the H5N1 virus affects diverse animal populations and poses significant risks to human health, ecosystems, and economies worldwide. At Promega, we are dedicated to equipping researchers and public health professionals with the tools they need to navigate and address these complex challenges.

Understanding H5N1 and Its Impact

A Global Challenge

The H5N1 outbreak has led to the depopulation of over 300 million birds across 108 countries, spanning five continents. The virus has infected over 500 bird species and at least 70 mammalian species, including endangered California condors and polar bears (1). The virus has had significant economic repercussions, particularly in the poultry industry, with 168 million birds culled in the United States to date (2). Recent human infections, primarily among farm workers, highlight the need for continued vigilance and robust surveillance systems.

The One Health initiative takes a holistic approach to managing disease outbreaks such as bird flu.
Continue reading “One Health and H5N1: Promega’s Commitment to Holistic Solutions”

Can Fungi Help Clean Up Environmental Contaminants? 

Posted on by Shannon Sindermann
Fly agaric or Fly amanita (Amanita muscaria) is a basidiomycete of the genus Amanita.

Polycyclic aromatic hydrocarbons (PAHs) are widespread environmental pollutants found in industrial waste, fossil fuel combustion and creosote-treated wood, to name a few. Due to these industrial activities, there are multiple pathways for human exposure. These compounds pose significant health risks due to their carcinogenic, teratogenic and mutagenic properties yet removing them from contaminated sites remains a challenge. Traditional remediation techniques, such as dredging and chemical treatment, are costly and can further disrupt ecosystems (1).  

Mycoremediation—using fungi to break down pollutants into intermediates with lower environmental burden—offers a sustainable, low-cost alternative for PAH degradation. While past research focused on basidiomycete fungi like white rot fungi, these have been unreliable in large-scale field applications. This study investigates an alternative approach: leveraging naturally occurring ascomycete fungi from creosote-contaminated sediments to enhance PAH degradation (1). 

Continue reading “Can Fungi Help Clean Up Environmental Contaminants? “

Understanding and Combating Legionella in Water Systems with Viability PCR

Posted on by Anna Bennett

Water plays a vital role in countless aspects of daily life—drinking, cooling, recreation and more. However, the same systems that deliver these benefits can also harbor Legionella, a waterborne bacteria responsible for Legionnaires’ disease, a severe form of pneumonia (1). Legionella thrives in stagnant aquatic environments, many of which are human-made and common in modern infrastructure, like in cooling towers, hot tubs and complex building water systems. In this blog, we explore the risks posed by Legionella, the limitations of traditional detection methods and how advanced tools at Promega are transforming water safety monitoring. 

3D illustration showing legionella pneumophilia bacteria in water
Continue reading “Understanding and Combating Legionella in Water Systems with Viability PCR”